Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Blood Science > Bleeding Disrders > Flashcards

Bleeding Disrders Flashcards

1
Q

Causes of abnormal bleeding

A
  1. Vascular disorders
  2. Thrombocytopenia
  3. Defective platelet function
  4. Defective coagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common symptoms of bleeding disorders

A

• Epistaxis
• Gingivalbleeds
• Bruising
• PurpuraorPetechiae
• Menorrhagia
• Jointbleeds
• Musclebleeds
• Chronicanaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Platelets /vessel wall diseases

A

-mucosal bleeding is common
-petechiae is common
-deep haematomas are rare
-persistent bleeding from skin cuts
-equal in both genders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Coagulation diseases

A

-rare mucosal bleeding
-rare petechiae
-deep heamatomas
-minimal bleeding from skin cuts
-more than 80% affected are males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 types of bleeding disorders

A

• Quantitative (reduced number) ,(<150 x 109/L)
• Thrombocytopenia

• Qualitative (reduced function)
• Acquired
• Inherited (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

THROMBOCYTOPENIA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Thrombocytopenia

A

• QuantitativeDisorder
• Plateletcountbelow150x109/L • Mostcommonplateletdisorder • Mostcommonlyacquired
• Reducedproduction(moresevere)orincreaseddestruction
• Plateletcounts>50×109/L-donotleadtoclinicalproblems.
• Plateletcounts<30×109/L-bruisingandpurpuraandprolongedbleedingtimes. • Plateletcount<10×109/L-Clinicallysignificantspontaneousbleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of thrombocytopia

A

• Conditions that cause systemic thrombosis
• Thrombotic thrombocytopenic purpura (TTP) • Disseminated intravascular coagulation (DIC)
• Cause consumption of platelets.
• Autoimmune diseases
• Immune thrombocytopenia (ITP)
• Form antibodies against platelets initiating their removal

• Drug-induced thrombocytopenia
• Heparin induced thrombosis (HIT)
• Vaccine-induce thrombosis and thrombocytopenia (VITT)

• Conditions that alter the bone marrow
• Aplastic anaemia
• Cancer and cancer treatments
• Infections
• Hypersplenism
• Removes too many platelets • Pregnancy
• Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Inherited bleeding disorders

A

-they are qualitative disorders
-are rare
-they affect various platelet function eg:adhesion,secretion and aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of inherited bleeding disorders

A

Bernard-Soulier Syndrome

Glanzmann Thrombasthenia

Gray Platelet Syndrome

Hermansky-Pudlak Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bernard-Soulier Syndrome

A

GPIb/XI deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glanzmann Thrombasthenia

A

AIIbb3 (GPIIb-IIIa) deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gray Platelet Syndrome

A

-granule deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hermansky-Pudlak Syndrome

A

Dense granule deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ACQUIRED PLATELET DYSFUNCTION DISORDERS

A

• Qualitative Disorders
• Anti-platelet drugs e.g. Aspirin and Clopidogrel
work to inhibit platelet function
• These effects last for the life of the platelet, approximately 7 to 10 days.
• During this time, exposed platelets have reduced function and do not respond effectively.
• Anti-platelet drugs are often associated with increased bleeding risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

COAGULATION RELATED BLEEDING DISORDERS

A

2 types:

• Quantitative (reduced amounts of coagulation factors) • Acquired
• DIC
• Vitamin K deficiency • Inherited
• Haemophilia A and B • VWD
• Qualitative (reduced function of coagulation factors) • Inherited
• VWD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DIC(acquired coagulation)

A

• Inappropriate activation of blood coagulation
• Generation and deposition of fibrin
• Microvascular thrombi form in
various organs
• Consumption and subsequent exhaustion of coagulation proteins and platelets
• Clinical features usually dominated by bleeding
• Caused by a wide variety of conditions such as trauma, shock, infection and pregnancy complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pathogenenis meaning

A

Development of for example a disease

19
Q

Pathogenesis of DIC

A

Pro inflammatory cytokines are generated and monocytes are activated.

Bacteria cause up regulation of tissue factor aswell as the release of micro practicals expressing tissue factor activating coagulation

Cytokines cause the activation of endothelial cells=imparting anti coagulation mechanism and down regulates Fibrinolysis by generating increased amounts of plasminogen activator inhibitor

20
Q

Vitamin k deficiency(acquired coagulation disorder)

A

Vitamin K serves as an essential cofactor for a carboxylase that catalyses carboxylation of glutamic acid residues on vitamin K-dependent proteins
• Key vitamin K-dependent proteins include:
• Coagulation factors: factors II (prothrombin), VII, IX and X
• Coagulation inhibitors: proteins C, S and Z
• Need carboxylation to be active

21
Q

Vitamin k cycle

A

-Gamma carboxylated
2+ glutamic acid bind Ca ions

-Induces a shape change in Vitamins dependent proteins

-This then allowsthese proteins to bind phospholipids

22
Q

CAUSES OF VITAMIN K DEFICIENCY

A

• Malabsorption of fat-soluble vitamins
• Oral anticoagulation therapy (e.g. warfarin)
• Liver disease – alters absorption
• Dietary deficiency associated with antibiotic treatment that destroys gut bacteria that can synthesize vitamin K
• Newborn infants have low levels of vitamin K and are at risk of intracranial bleeds – given vitamin K injections

23
Q

LIVER DISEASE

A

The clotting factors that are produced by the liver are I, II, V, VII, IX and X and some FVIII
• The order in which the levels of these are reduced in liver disease is:
• VII - the earliest to be reduced
• II, X - next to be reduced
• I, V - these persist despite severe liver disease
• Patientswithliverdiseasethereforehaveprolonged prothrombin times
• PatientswithseverediseasewillhaveprolongedPT and APTT times
• Patients have a tendency to bleed

24
Q

MASSIVE BLOOD LOSS/TRAUMA

A

• Defined as the loss of:
• One blood volume within a 24-hour period
• 50% blood volume loss within 3 hours
• Rate of loss of 150 ml/hour.
• Packed red blood cells contain very little plasma so patients usually given replacement clotting factors using fresh frozen plasma.
• Platelets and fibrinogen (cryoprecipitate) should be replaced as required.
• Surgical control of bleeding should be obtained as soon as possible

25
Q

AUTO/ALLOIMMUNE COAGULATION DISORDERS

A

Caused by circulating antibodies to coagulation factors
• Alloantibodies to factorVIII occur in5-10% of haemophiliacs

Lupus anticoagulant
• Interferes with lipoproteins and the
phospholipid-dependant stages of coagulation
• Anti-phospholipidsyndrome–LA orAPS inhibitor
is detected in 10%of systemic lupus erythematosus(SLE)patients

26
Q

Laboratory tests to check if the patient has acquired coagulation disorder

A

Platelet count :
1)liver disease=low
2)DIC=LOW
3)massive transfusion=low
4)Circulating anticoagulant=normal

Pt
Liver disease/DIC/massive transfusion/circulating anticoagulant =prolonged

Activated partial thromboplastin time
Prolonged for everything

27
Q

Haemophilia

A

X chromosome-linked bleeding disorders
• Deficiency of FVIII is haemophilia A
• Deficiency of FIX is haemophilia B (Christmas disease)
• Prolonged and excessive bleeding

28
Q

GENETICS OF HAEMOPHILIA

A

• HaemophiliaAandBareX-linkedrecessive–predominantlyaffectsmales
• GenesareclosetogetheronthelongarmoftheXchromosome.
• Deletionsaccountfor5%ofcasesframeshift,missenseandinversionsarealsoseen.
• ‘Flip’inversion-50%ofseverecases
• Femalecarrierswillhave variable levels of FVIII of FIX due to random inactivation of theX chromosome

29
Q

HAEMOPHILIA B – FACTOR IX

A

• FactorIXisakeyfactorofthe INTRINSIC pathway
• WhydoesFIXdeficiencyresultina profound bleedingdisorder?
FIX activation to FIXaby thrombin
Amplification!

30
Q

HAEMOPHILIA A – FACTOR VIII

A

• Inheritedbleedingdisorderresultingfromlowfunctionallevelsofbloodcoagulation factor VIII
• CausedbymutationsinthecoagulationfactorVIIIgene
• Mostcommonofthesevereinheritedbleedingdisorders
• (1caseper5,000male births)
• Bleedingepisodesmaybemorefrequentinchildhoodandadolescencethanin adulthood.
• Approximately10%ofcarrierfemalesareatriskforbleeding

31
Q

HAEMOPHILIA - DIAGNOSIS

A

• Family history - Usually diagnosed in the neonatal or prenatal period.
• In sporadic cases (30%–40% of cases), the severe patients are diagnosed < 1 year
old because of mucosal or soft tissue haemorrhages, usually after trauma
• Haemophilia A is diagnosed in individuals with low factor VIII clotting activity in the
presence of a normal von Willebrand factor (VWF) level
• Molecular genetic testing of F8, the gene encoding factor VIII, identifies pathogenic variants in as many as 98% of individuals with haemophilia A

32
Q

HAEMOPHILIA - SYMPTOMS

A

➢ General - Weakness and orthostasis
➢ Musculoskeletal(joints)
➢ Tingling, cracking, warmth, pain,
➢ Centralnervoussystem(CNS)
➢ Headache,stiff neck,vomiting,lethargy irritability, spinal cordsyndromes
➢ Gastrointestinal(GI)
➢ Haematemesis, abdominal pain
➢ Genitourinary
➢ Haematuria,post-circumcisionbleeding
➢ Excessivebleeding with routinedental procedures

33
Q

Lab tests for haemophilia

A

Abnormal
• Activated Partial Thromboplastin Time (APTT) - increased
• Factor VIII/FIX clotting assay – Low

Normal
• VWF levels normal and normal function
• Plateletcount
• Prothrombintime(PT)
• Platelet function analysis (PFA-100)

34
Q

HAEMOPHILIA - TREATMENTS

A

• Severe–concentratedfactorsusually prophylactically to prevent bleeds

• Moderate–concentratedfactorswhenneeded • DDAVP(Desmopressin)whichinducesashort
term rise in FVIII and von Willebrandfactor • Prothrombincomplexconcentrates(FIX)

• Mild –DDAVPorProthrombinconcentrateswhen compromised ie surgical procedures

35
Q

Von willebrands disease(inheritd)

A

• Most common hereditary coagulation abnormality affecting ~1% of the population
• QuantitativeorqualitativedefectinvonWillebrandfactor
• Divided into three major categories
1. Type I – Partial quantitative vWF deficiency
2. Type II – Qualitative vWF deficiency
3. TypeIII -TotalvWFdeficiency
• Affects individuals of all ethnic backgrounds, and the clinical symptoms can present at any age

36
Q

VON WILLEBRANDS FACTOR (VWF)

A

• VWF is a large multimeric glycoprotein.
• Synthesised by endothelial cells and in megakaryocytes
• Endothelial cells are the main source of circulating VWF
• Mature VWF is stored as Weibel-Palade bodies in endothelial cells
and in the alpha granules of platelets

• VWF is important for both PRIMARY and SECONDARY Haemostasis
• Primary: Serves as a bridge between GPIb/IX receptors on activated
platelets and subendothelial collagen exposed when the vessel is injured
• Secondary: Complexes and stabilises FVIII in plasma

37
Q

VON WILLEBRANDS DISEASE (VWD) - CLASSIFICATION

A

• Type 1: mild to moderate quantitative deficiency of VWF
• Type 3: severe quantitative deficiency of VWF
• Type 2: qualitative deficits in VWF.
• Types 1, 2A, 2B, and 2M autosomal dominant trait
• Type 3 and 2N is inherited as autosomal recessive

38
Q

Symptoms of VWD

A

• Nosebleeds (epistaxis) and haematomas
• Easy bruising - common but nonspecific
• Prolonged bleeding - after minor trauma to skin or mucous membranes
• Oralcavitybleeding
• Excessive menstrual bleeding (menorrhagia)
• Improvement of bleeding symptoms with use of oral contraceptives
• Gastrointestinal bleeding (but rarely occurs)
• Delayed bleeding - may occur up to several weeks after surgery
• Exacerbation of bleeding symptoms - After ingestion of aspirin

39
Q

Lab finding for vwd

A

Abnormal
• Plateletfunctionanalysis(PFA)–prolonged
• VWF levels low or abnormal function
• Activated Partial Thromboplastin Time (APTT) – normal or increased
• Factor VIII clotting assay – may be slightly reduced
Normal
• Factor IX assay
• Plateletcount
• Prothrombintime(PT)

40
Q

Lab assays for vwd

A

• Quantitative – VWF:Ag assay
• Determines the level VWF in the blood by measuring the vWF protein (antigen)
• Measures the concentration of VWF, gives no indication as to function.
• Typically by ELISA or immunoassays

• Qualitative - VWF activity (Ristocetin Induced Platelet Aggregation)

• Multimer analysis – differential diagnosis (distinguish between different types of VWD)

41
Q

VON WILLEBRANDS ACTIVITY ASSAY

A

• Ristocetin–bindstoVWFandplateletGPIbtocause agglutination
• Ristocetinusedasanantibioticuntilitwasrecognisedto causethrombocytopenia
• RistocetinCofactor[vWF:RCo]assay
measures the ability of a patient’s plasma to agglutinateplateletsinthepresenceof theantibiotic Ristocetin.
• TherateofRistocetininducedagglutinationis relatedtothe concentrationandfunctional activity of the plasma von Willebrand factor.

42
Q

VON WILLEBRANDS DISEASE – MULTIMER ANALYSIS

A

Absence of multimers depending on the type of disease

43
Q

VON WILLEBRANDS DISEASE (VWD) - TREATMENT

A

• TwomaintreatmentoptionsforpatientswithvonWillebranddisease(vWD)
• Desmopressin (DDAVP)
• von Willebrand factor/factor VIII (vWF/FVIII)concentrates
• DDAVPcausesthereleaseofVWFfromWeibelPaladebodies
• PlatelettransfusionsmaybehelpfulinsomepatientswithvWD(eg,type3)
• CryoprecipitateandfreshfrozenplasmacontainfunctionalvonWillebrandfactor(vWF) but should be avoided if at all possible because of the potential transmission of viral disease.

Blood Science (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions